Trial | NCT01015937  Report issue

Title

Effect of Turmeric on Diabetic Nephropathy

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    enalapril curcuma longa losartan ...

  • Study Participants

    50
The purpose of this study is to investigate whether turmeric is effective in improvement of diabetic nephropathy and in decrease in the amount of proteinuria and cytokine levels.
Diabetic nephropathy is leading cause of ESRF that many therapy recommended for it. In this study, we investigate effect of turmeric on diabetic nephropathy, thus we selected diabetic nephropathy patients and divided them into 2 groups. One group received turmeric + ACE inhibitor + Angiotensin II receptor blocker (ARB) and the second group received only ACE inhibitor + ARB.
Study Started
Mar 31
2008
Primary Completion
Jun 30
2009
Study Completion
Aug 31
2009
Last Update
Nov 18
2009
Estimate

Drug Turmeric extract

turmeric 500 mg TID for 45 days

  • Other names: turmeric

Drug Angiotensin-converting enzyme (ACE) inhibitor + Angiotensin-II type 1 receptor (ATI) blocker

maximum dosage as patient tolerated for 45 days

  • Other names: enalapril, losartan

Turmeric Active Comparator

diabetic nephropathy patient more than 300 mg/proteinuria

ACE inhibitor + ATI blocker Active Comparator

diabetic nephropathy more than 300 mg/day proteinuria

Criteria 

Inclusion Criteria:

diabetic nephropathy
more than 300 mg proteinuria/day
age more than 18 years old

Exclusion Criteria:

DM type 1
No Results Posted